Personalized afib ablation using body surface mapping
Part of Heart & circulation clinical trials.
This trial uses a special body-surface mapping technique to guide personalized ablation for persistent atrial fibrillation (afib). It aims to improve outcomes for people with an enlarged left atrium who have not had prior ablation.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You have persistent atrial fibrillation (a type of irregular heartbeat that lasts longer than a week)
- You are scheduled for your first catheter ablation (a procedure to fix the rhythm)
- Your left atrium (upper heart chamber) is enlarged, as shown on imaging tests
- You are 18 or older
- You are not pregnant or breastfeeding
- You have not had a prior stroke or mini-stroke (TIA)
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests whether using a special heart-mapping device during ablation (a procedure to fix irregular heartbeats) can improve outcomes for people with persistent atrial fibrillation and an enlarged left heart chamber.
This study compares two techniques for treating persistent atrial fibrillation: one uses standard anatomy-based ablation, and the other uses a special mapping system to guide the procedure. It aims to find which method works better for people who have not had prior ablation.
This trial tests a new way to map the heart's electrical signals to help doctors better target and treat atrial fibrillation (an irregular heartbeat). If you're having a procedure to treat AF, this study may help improve the success of your treatment.
This trial compares two catheter ablation techniques for people with persistent atrial fibrillation (a type of irregular heartbeat that doesn't go away on its own). It will test whether a more extensive ablation (burning more heart tissue) works better than the standard procedure of isolating the pulmonary veins (the veins that bring blood from the lungs to the heart). If you have this condition and have had at least one episode in the past year, this study might help you find a more effective treatment.
This trial is testing a specific approach to catheter ablation for people with persistent atrial fibrillation. It aims to improve how abnormal heart tissue is targeted to help restore a normal rhythm.
This trial uses an artificial intelligence system (vMap) to find and target abnormal electrical signals outside the pulmonary veins that may be driving atrial fibrillation (AF). The goal is to improve ablation results for people with persistent or recurrent AF.
Hear when a new Atrial Fibrillation (AF) trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.